BioSpace News Archive

Policy

Janssen Submits Ponesimod New Drug Application to the U.S. FDA for Treatment of Adults with Relapsing Multiple Sclerosis

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a New Drug Application to the U.S.

March 18, 2020
·
7 min read
Business

BIOLASE Reschedules Fourth Quarter 2019 Earnings Call To March 26, 2020

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has rescheduled its fourth quarter and full year 2019 earnings conference call to Thursday, March 26, 2020, due to scheduling conflicts.

March 18, 2020
·
3 min read
Deals

Agilent Technologies Announces Cash Dividend of 18 Cents Per Share

Agilent Technologies Inc. announced that a quarterly dividend of 18 cents per share of common stock will be paid on April 22, 2020, to all shareholders of record as of the close of business on March 31, 2020.

March 18, 2020
·
1 min read
Biotech Bay

Portola Pharmaceuticals Announces Proactive Steps Supporting Public Health Efforts to Combat Coronavirus (COVID-19)

Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced proactive steps the Company is taking in support of public heath efforts to prevent furtherspread of coronavirus (or COVID-19) around the globe.

March 18, 2020
·
6 min read
Policy

Jury Invalidates PacBio’s Patents in U.S. Patent Trial Against Oxford Nanopore

After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences in this litigation.

March 18, 2020
·
1 min read
BioCapital

QIAGEN launches QIAstat-Dx test kit for detection of SARS-CoV-2 coronavirus in Europe following CE marking

First syndromic testing solution to obtain CE marking as an in vitro diagnostic (“IVD”) for the detection of SARS-CoV-2 , and is now available for purchase in the European Union

March 18, 2020
·
2 min read